SRR
Basic information
Region (hg38): 17:2303383-2325260
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SRR gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 15 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 13 | 14 | ||||
Total | 0 | 0 | 28 | 2 | 0 |
Variants in SRR
This is a list of pathogenic ClinVar variants found in the SRR region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-2303657-G-C | not specified | Uncertain significance (Sep 15, 2021) | ||
17-2303674-C-T | not specified | Uncertain significance (Aug 04, 2023) | ||
17-2303711-C-T | not specified | Uncertain significance (May 09, 2024) | ||
17-2315669-C-G | not specified | Likely benign (Jan 24, 2023) | ||
17-2315705-T-C | not specified | Uncertain significance (Oct 25, 2022) | ||
17-2317874-G-A | not specified | Uncertain significance (Sep 29, 2023) | ||
17-2317874-G-C | not specified | Uncertain significance (Aug 12, 2021) | ||
17-2318883-T-C | not specified | Uncertain significance (Dec 06, 2023) | ||
17-2321405-G-A | not specified | Uncertain significance (Mar 07, 2024) | ||
17-2321542-G-T | not specified | Uncertain significance (Sep 10, 2024) | ||
17-2321597-G-C | not specified | Uncertain significance (Oct 30, 2023) | ||
17-2321600-T-C | not specified | Uncertain significance (May 16, 2022) | ||
17-2323161-A-G | not specified | Uncertain significance (Oct 27, 2023) | ||
17-2323211-G-A | not specified | Uncertain significance (Jan 18, 2023) | ||
17-2323275-G-A | not specified | Uncertain significance (Jan 19, 2022) | ||
17-2323314-A-G | not specified | Uncertain significance (Nov 13, 2024) | ||
17-2323317-T-A | not specified | Uncertain significance (May 08, 2024) | ||
17-2323736-C-G | not specified | Uncertain significance (Dec 15, 2022) | ||
17-2323738-A-C | not specified | Uncertain significance (Aug 04, 2023) | ||
17-2323748-A-G | not specified | Uncertain significance (Sep 25, 2024) | ||
17-2323751-G-A | not specified | Uncertain significance (Nov 07, 2022) | ||
17-2323758-C-T | not specified | Uncertain significance (Sep 25, 2024) | ||
17-2323860-C-T | not specified | Uncertain significance (Feb 15, 2023) | ||
17-2324231-T-C | not specified | Uncertain significance (Dec 19, 2023) | ||
17-2324249-G-A | not specified | Uncertain significance (Feb 21, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SRR | protein_coding | protein_coding | ENST00000344595 | 7 | 21878 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00580 | 0.974 | 125704 | 0 | 44 | 125748 | 0.000175 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.881 | 148 | 181 | 0.816 | 0.00000849 | 2206 |
Missense in Polyphen | 53 | 56.7 | 0.93474 | 718 | ||
Synonymous | 0.0312 | 64 | 64.3 | 0.995 | 0.00000311 | 705 |
Loss of Function | 2.03 | 6 | 14.3 | 0.419 | 6.70e-7 | 177 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000529 | 0.000529 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000217 | 0.000217 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.0000971 | 0.0000967 |
Middle Eastern | 0.000217 | 0.000217 |
South Asian | 0.000196 | 0.000196 |
Other | 0.000491 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the synthesis of D-serine from L-serine. D- serine is a key coagonist with glutamate at NMDA receptors. Has dehydratase activity towards both L-serine and D-serine. {ECO:0000269|PubMed:11054547, ECO:0000269|PubMed:20106978}.;
- Pathway
- Glycine, serine and threonine metabolism - Homo sapiens (human);3-Phosphoglycerate dehydrogenase deficiency;Non Ketotic Hyperglycinemia;Glycine and Serine Metabolism;Dimethylglycine Dehydrogenase Deficiency;Hyperglycinemia, non-ketotic;Dimethylglycine Dehydrogenase Deficiency;Sarcosinemia;Dihydropyrimidine Dehydrogenase Deficiency (DHPD);Metabolism of amino acids and derivatives;Metabolism;serine and glycine biosynthesis;Amino acid synthesis and interconversion (transamination);Serine biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.220
Intolerance Scores
- loftool
- 0.452
- rvis_EVS
- -0.47
- rvis_percentile_EVS
- 23.04
Haploinsufficiency Scores
- pHI
- 0.506
- hipred
- N
- hipred_score
- 0.293
- ghis
- 0.615
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.683
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Srr
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- L-serine metabolic process;L-serine biosynthetic process;brain development;aging;serine family amino acid metabolic process;response to lipopolysaccharide;pyruvate biosynthetic process;response to morphine;protein homotetramerization;D-serine metabolic process;D-serine biosynthetic process
- Cellular component
- cytoplasm;cytosol;plasma membrane;neuronal cell body;apical part of cell
- Molecular function
- magnesium ion binding;L-serine ammonia-lyase activity;calcium ion binding;ATP binding;D-serine ammonia-lyase activity;glycine binding;threonine racemase activity;PDZ domain binding;pyridoxal phosphate binding;serine racemase activity;protein homodimerization activity